retatrutide nash trial nonalcoholic fatty liver disease Current therapies and new developments in retatrutide nonalcoholic fatty liver disease Xia & He Publishing

In animal models, GIP agonists were shown to have beneficial effects on tissue-level bone material properties

Managing GLP-1 costs Thus, one growing challenge for managing costs related to GLP-1 medicines is the sheer complexity and rapid activity in the drug pipeline

doi:10.1016/j.euroneuro.2025.08.002 106

It's often called the 'master antioxidant' for a reason it helps fight free radicals, supports a strong immune system, and can even contribute to that natural glow we all chase

These researchers discovered that castration caused 4-hydroxynonenal and 8-hydroxy-20-deoxy-guanosine protein adducts in the regressing epithelium, which suggests oxidative damage